Erythropoietin for preterm infants with hypoxic ischaemic encephalopathy
Referencias
Additional references
Aydin A, Genc K, Akhisaroglu M, Yorukoglu K, Gokmen N, Gonullu E. Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic‐ischemic brain injury. Brain and Development 2003;25(7):494‐8.
Bierer R, Peceny MC, Hartenberger CH, Ohls RK. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 2006;118(3):e635‐40.
Bode MM, O'shea TM, Metzguer KR, Stiles AD. Perinatal regionalization and neonatal mortality in North Carolina, 1968‐1994. American Journal of Obstetrics and Gynecology 2001;184(6):1302‐7.
Buser JR, Segovia KN, Dean JM, Nelson K, Beardsley D, Gong X, et al. Timing of appearance of late oligodendrocyte progenitors coincides with enhanced susceptibility of preterm rabbit cerebral white matter to hypoxia‐ischemia. Journal of Cerebral Blood Flow and Metabolism 2010;30(5):1053‐65.
Campana WM, Misasi R, O'Brien JS. Identification of a neurotrophic sequence in erythropoietin. International Journal of Molecular Medicine 1998;1(1):235‐41.
Chaudhari T, McGuire W. Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic‐ischaemic encephalopathy. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD006817.pub2]
Chen J, Connor KM, Aderman CM, Smith LE. Erythropoietin deficiency decreases vascular stability in mice. Journal of Clinical Investigation 2008;118(2):526‐33.
Coronel F, Garcia‐Mena M, Martinez R. Pure red‐cell aplasia induced by anti‐erythropoietin antibodies in peritoneal dialysis. Clinical Nephrology 2004;61(2):155‐8.
Dame C, Fahnenstich H. Don't give up on erythropoietin as a neuroprotective agent. Pediatrics 2005;116(2):521‐2.
Demers EJ, McPherson RJ, Juul SE. Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia‐ischemia. Pediatric Research 2005;58(2):297‐301.
Derrick M, Luo NL, Bregman JC, Jilling T, Ji X, Fisher K, et al. Preterm fetal hypoxia‐ischemia causes hypertonia and motor deficits in the neonatal rabbit: a model for human cerebral palsy?. Journal of Neuroscience 2004;24(1):24‐34.
Edwards AD, Azzopardi DV. Therapeutic hypothermia following perinatal asphyxia. Archives of Disease in Childhood. Fetal and Neonatal Edition 2006;91(2):F127‐31.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. British Medical Journal 1997;315(7109):629‐34.
Evans DJ, Levene MI, Tsakmakis M. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD001240.pub2]
Finer NN, Robertson CM, Richards RT, Pinnell LE, Peters KL. Hypoxic‐ischemic encephalopathy in term neonates: perinatal factors and outcome. The Journal of Pediatrics 1981;98(1):112‐7.
Genc S, Akhisaroglu M, Kuralay F, Genc K. Erythropoietin restores glutathione peroxidase activity in 1‐methyl‐4‐phenyl‐1,2,5,6‐tetrahydropyridine‐induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neuroscience Letters 2002;321(1‐2):73‐6.
Glass HC, Ferriero DM. Treatment of hypoxic‐ischemic encephalopathy in newborns. Current Treatment Options in Neurology 2007;9(6):414‐23.
Gonzalez FF, Miller SP. Does perinatal asphyxia impair cognitive function without cerebral palsy?. Archives of Disease in Childhood. Fetal and Neonatal Edition 2006;91(6):F454‐9.
Gunn AJ, Bennet L. Brain cooling for preterm infants. Clinics in Perinatology 2008;35(4):735‐48.
Hack M, Youngstrom EA, Cartar L, Schluchter M, Taylor HG, Flannery D, et al. Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years. Pediatrics 2004;114(4):932‐40.
Harbord RM, Egger M, Sterne JA. A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints. Statistics in Medicine 2006;25(20):3443–57.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org2011.
Hunt R, Osborn D. Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD003484]
Itoo BA, Al‐Hawsawi ZM, Khan AH. Hypoxic ischemic encephalopathy. Incidence and risk factors in North Western Saudi Arabia. Saudi Medical Journal 2003;24(2):147‐53.
Jacobs S, Hunt R, Tarnow‐Mordi W, Inder T, Davis P. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD003311.pub2]
Johnston MV. Hypoxic‐ischemic encephalopathy. Current Treatment Options in Neurology 2000;2(2):109‐16.
Juul S, Felderhoff‐Mueser U. Epo and other hematopoietic factors. Seminars in Fetal and Neonatal Medicine 2007;12(4):250‐8.
Juul SE, McPherson RJ, Bauer LA, Ledbetter KJ, Gleason CA, Mayock DE. A phase I/II trial of high‐dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 2008;122(2):383‐91.
Kawakami M, Sekiguchi M, Sato K, Kozaki S, Takahashi M. Erythropoietin receptor‐mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. Journal of Biological Chemistry 2001;276(42):39469‐75.
Kecskes Z, Healy G, Jensen A. Fluid restriction for term infants with hypoxic‐ischaemic encephalopathy following perinatal asphyxia. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD004337.pub2]
Kellert BA, McPherson RJ, Juul SE. A comparison of high‐dose recombinant erythropoietin treatment regimens in brain‐injured neonatal rats. Pediatric Research 2007;61(4):451‐5.
Kim SS, Lee KH, Sung DK, Shim JW, Kim MJ, Jeon GW, et al. Erythropoietin attenuates brain injury, subventricular zone expansion, and sensorimotor deficits in hypoxic‐ischemic neonatal rats. Journal of Korean Medical Science 2008;23(3):484‐91.
Konishi Y, Chui DH, Hirose H, Kunishita T, Tabira T. Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Research 1993;609(1‐2):29‐35.
Kumral A, Baskin H, Gokmen N, Yilmaz O, Genc K, Genc S, et al. Selective inhibition of nitric oxide in hypoxic‐ischemic brain model in newborn rats: is it an explanation for the protective role of erythropoietin?. Biology of the Neonate 2004;85(1):51‐4.
Kumral A, Uysal N, Tugyan K, Sonmez A, Yilmaz O, Gokmen N, et al. Erythropoietin improves long‐term spatial memory deficits and brain injury following neonatal hypoxia‐ischemia in rats. Behavioural Brain Research 2004;153(1):77‐86.
Kumral A, Gonenc S, Acikgoz O, Sonmez A, Genc K, Yilmaz O, et al. Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic‐ischemic brain injury in neonatal rats. Biology of the Neonate 2005;87(1):15‐8.
Kumral A, Genc S, Ozer E, Yilmaz O, Gokmen N, Koroglu TF, et al. Erythropoietin downregulates bax and DP5 proapoptotic gene expression in neonatal hypoxic‐ischemic brain injury. Biology of the Neonate 2006;89(3):205‐10.
Kuriyama S, Otsuka Y, Iida R, Matsumoto K, Hosoya T. Morning blood pressure at home predicts erythropoietin‐induced hypertension in patients with chronic renal diseases. Clinical and Experimental Nephrology 2007;11(1):66‐70.
Li Y, Hu X, Lu Z. Erythropoietin in the treatment of encephalopathy associated with carbon monoxide poisoning. Progress in Neuropsychopharmacology and Biological Psychiatry 2009;33(4):735‐8.
Logitharajah P, Rutherford MA, Cowan FM. Hypoxic‐ischemic encephalopathy in preterm infants: antecedent factors, brain imaging, and outcome. Pediatric Research 2009;66(2):222‐9.
Low JA. Determining the contribution of asphyxia to brain damage in the neonate. Journal of Obstetrics and Gynaecology Research 2004;30(4):276‐86.
McClure MM, Threlkeld SW, Fitch RH. Auditory processing and learning/memory following erythropoietin administration in neonatally hypoxic‐ischemic injured rats. Brain Research 2007;1132(1):203‐9.
McGuire W, Fowlie PW, Evans DJ. Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD003955.pub2]
McPherson RJ, Juul SE. Erythropoietin for infants with hypoxic‐ischemic encephalopathy. Current Opinion in Pediatrics 2010;22(2):139‐45.
Miranda MJ, Olofsson K, Sidaros K. Noninvasive measurements of regional cerebral perfusion in preterm and term neonates by magnetic resonance arterial spin labeling. Pediatric Research 2006;60(3):359‐63.
Ohls RK, Ehrenkranz RA, Das A, Dusick AM, Yolton K, Romano E, et al. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 2004;114(5):1287‐91.
Ohlsson A, Aher SM. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD004863.pub3]
Palmer C. Hypoxic‐ischemic encephalopathy. Therapeutic approaches against microvascular injury, and role of neutrophils, PAF, and free radicals. Clinics in Perinatology 1995;22(2):481‐517.
Palmer C, Menzies SL, Roberts RL, Pavlick G, Connor JR. Changes in iron histochemistry after hypoxic‐ischemic brain injury in the neonatal rat. Journal of Neuroscience Research 1999;56(1):60‐71.
Perlman JM. Intervention strategies for neonatal hypoxic‐ischemic cerebral injury. Clinical Therapeutics 2006;28(9):1353‐65.
Powers WJ, Rosenbaum JL, Dence CS, Markham J, Videen TO. Cerebral glucose transport and metabolism in preterm human infants. Journal of Cerebral Blood Flow and Metabolism 1998;18(6):632‐8.
The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2011.
Salhab WA, Perlman JM. Severe fetal acidemia and subsequent neonatal encephalopathy in the larger premature infant. Pediatric Neurology 2005;32(1):25‐9.
Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Archives of Neurology 1976;33(10):696‐705.
Schmidt JW, Walsh WF. Hypoxic‐ischemic encephalopathy in preterm infants. Journal of Neonatal‐Perinatal Medicine 2010;4(3):277‐84.
Singh D, Kumar P, Narang A. A randomized controlled trial of phenobarbital in neonates with hypoxic ischemic encephalopathy. The Journal of Maternal‐Fetal and Neonatal Medicine 2005;18(6):391‐5.
Slusarski JD, McPherson RJ, Wallace GN, Juul SE. High‐dose erythropoietin does not exacerbate retinopathy of prematurity in rats. Pediatric Research 2009;66(6):625‐30.
Sobh MA, el‐Tantawy AE, Said E, Atta MG, Refaie A, Nagati M, et al. Effect of treatment of anaemia with erythropoietin on neuromuscular function in patients on long term haemodialysis. Scandinavian Journal of Urology and Nephrology 1992;26(1):65‐9.
Springborg JB, Ma X, Rochat P, Knudsen GM, Amtorp O, Paulson OB, et al. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. British Journal of Pharmacology 2002;135(3):823‐9.
Statler PA, McPherson RJ, Bauer LA, Kellert BA, Juul SE. Pharmacokinetics of high‐dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatric Research 2007;61(6):671‐5.
Sugawa M, Sakurai Y, Ishikawa‐Ieda Y, Suzuki H, Asou H. Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neuroscience Research 2002;44(4):391‐403.
Sun Y, Calvert JW, Zhang JH. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 2005;36(8):1672‐8.
Talos DM, Follett PL, Folkerth RD, Fishman RE, Trachtenberg FL, Volpe JJ, et al. Developmental regulation of alpha‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex. Journal of Comparative Neurology 2006;497(1):61‐77.
van Handel M, Swaab H, de Vries LS, Jongmans MJ. Long‐term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: a review. European Journal of Pediatrics 2007;166(7):645‐54.
Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. The Journal of Experimental Medicine 2003;198(6):971‐5.
Wang YH, Zhu CL, Chen XY, Hu SH, Feng HQ, Wang XY. Effect of recombinant human erythropoietin for neurodevelopment in preterm infants. Chinese Journal of Practical Pediatrics 2006;21(1):59‐60.
Wilson‐Costello D, Friedman H, Minich N, Fanaroff AA, Hack M. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics 2005;115(4):997‐1003.
Wolf RF, Gilmore LS, Friese P, Downs T, Burstein SA, Dale GL. Erythropoietin potentiates thrombus development in a canine arterio‐venous shunt model. Thrombosis and Haemostasis 1997;77(5):1020‐4.
Zhu C, Kang W, Xu F, Cheng X, Zhang Z, Jia L, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic‐ischemic encephalopathy. Pediatrics 2009;124(2):e218‐26.
